Almost 6 top pharmaceutical companies have been pulled into a legal battle by the federal prosecutors in Brooklyn over the opioid crisis. The US Attorney’s Office in Brooklyn has ordered the manufacturers Teva Pharmaceutical Industries, Johnson & Johnson, Mallinckrodt, and Amneal Pharmaceuticals Inc. along with distributors McKesson Corp. and AmerisourceBergen Corp. to provide necessary evidence and witnesses as per the documents provided by the companies with the Securities and Exchange Commission (SEC). One of the documents clearly shows Teva understands the prospect of being a part of the broader investigation and monitoring programs plus reporting under the Controlled Substances Act.
The US Attorney’s Office in Brooklyn has not uttered a word about the issuing of the subpoenas to the companies. The lawsuit filed by the local government and state clearly hold the companies responsible for the opioid epidemic that has killed thousands of people in the last 2 decades. The companies that are targeted have denied the allegations. The subpoenas as per the Johnson & Johnson, McKesson Corp., and Mallinckrodt had been provided in filings with the SEC to the companies just a month back. Johnson & Johnson has made it clear that their opioid medications were sold within the laws of anti-diversion policies and procedures for distribution. As a part of the Controlled Substances Act, the subpoena has been provided to help investigate the monitoring programs and reporting of manufacturers and distributors.
Similarly, the US Attorney’s Office in Manhattan had filed charges against the Rochester Drug Cooperative for breaking federal narcotics laws as per the Controlled Substances Act. This is the first time that a pharmaceutical company in the US has been charged with breakings laws and these charges are normally put on the drug traffickers. In September, Governor Andrew Cuomo and the state Department of Financial Services had declared that the drug manufacturers will be sued and accused of defrauding New Yorkers of $2 Billion for marketing opioid.
Having more than 4 years of experience in the industry, it has been a couple of years for Ramona to be at
Medical Device News. She is responsible for anything that takes place in the Health Department, making her the sole leader of the department. She has also grabbed a couple of certificates to justify her role. Ramona appreciates a cool coffee shop, finds learning incredibly motivating, and is an aspirant urban farmer in her apartment.